ATE190501T1 - Bereitstellung einer für krebszellen cytotoxischen verbindung unter verwendung des weges von plasminogenaktivatormaterial - Google Patents
Bereitstellung einer für krebszellen cytotoxischen verbindung unter verwendung des weges von plasminogenaktivatormaterialInfo
- Publication number
- ATE190501T1 ATE190501T1 AT93914191T AT93914191T ATE190501T1 AT E190501 T1 ATE190501 T1 AT E190501T1 AT 93914191 T AT93914191 T AT 93914191T AT 93914191 T AT93914191 T AT 93914191T AT E190501 T1 ATE190501 T1 AT E190501T1
- Authority
- AT
- Austria
- Prior art keywords
- cancer cell
- providing
- compound
- cytotoxic compound
- activation material
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88978392A | 1992-05-28 | 1992-05-28 | |
| US5981393A | 1993-05-10 | 1993-05-10 | |
| PCT/US1993/005034 WO1993024141A1 (en) | 1992-05-28 | 1993-05-27 | Delivery of a cytotoxic compound to a cancer cell using a pathway of plasminogen activator material |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE190501T1 true ATE190501T1 (de) | 2000-04-15 |
Family
ID=26739215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93914191T ATE190501T1 (de) | 1992-05-28 | 1993-05-27 | Bereitstellung einer für krebszellen cytotoxischen verbindung unter verwendung des weges von plasminogenaktivatormaterial |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0643584B1 (de) |
| AT (1) | ATE190501T1 (de) |
| AU (1) | AU4394293A (de) |
| DE (1) | DE69328092T2 (de) |
| ES (1) | ES2143504T3 (de) |
| WO (1) | WO1993024141A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0880596A1 (de) * | 1995-12-28 | 1998-12-02 | Chiron Corporation | Rezeptorspezifische, chimäre, virale oberflächenpolypeptide für die übertragung von viralen oder nicht-viralen partikeln in zielzellen. |
| US6277818B1 (en) | 1998-10-29 | 2001-08-21 | Angstrom Pharmaceuticals, Inc. | Cyclic peptide ligands that target urokinase plasminogen activator receptor |
| US5994309A (en) | 1997-07-25 | 1999-11-30 | Angstrom Pharmaceuticals, Inc. | Anti-invasive and anti-angiogenic compositions and methods |
| AU2004290585A1 (en) * | 2003-11-18 | 2005-06-02 | Attenuon Llc | Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof |
| WO2007044892A2 (en) * | 2005-10-10 | 2007-04-19 | American Diagnostica, Inc. | Upar-binding molecule-drug conjugates and uses thereof |
| WO2008073312A2 (en) | 2006-12-08 | 2008-06-19 | Attenuon, Llc | Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
| US8877156B2 (en) | 2007-06-26 | 2014-11-04 | New York University | Contrast agents anchored by thiols on nanoparticles |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN165717B (de) * | 1986-08-07 | 1989-12-23 | Battelle Memorial Institute | |
| DK0467932T3 (da) * | 1989-04-07 | 2001-02-12 | Cancerforskningsfonden Af 1989 | Plasminogen-aktivator-receptor af urokinasetypen |
-
1993
- 1993-05-27 EP EP93914191A patent/EP0643584B1/de not_active Expired - Lifetime
- 1993-05-27 AT AT93914191T patent/ATE190501T1/de not_active IP Right Cessation
- 1993-05-27 DE DE69328092T patent/DE69328092T2/de not_active Expired - Fee Related
- 1993-05-27 AU AU43942/93A patent/AU4394293A/en not_active Abandoned
- 1993-05-27 WO PCT/US1993/005034 patent/WO1993024141A1/en active IP Right Grant
- 1993-05-27 ES ES93914191T patent/ES2143504T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0643584B1 (de) | 2000-03-15 |
| WO1993024141A1 (en) | 1993-12-09 |
| EP0643584A4 (de) | 1995-07-26 |
| AU4394293A (en) | 1993-12-30 |
| EP0643584A1 (de) | 1995-03-22 |
| DE69328092D1 (de) | 2000-04-20 |
| ES2143504T3 (es) | 2000-05-16 |
| DE69328092T2 (de) | 2000-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0504327A4 (en) | Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof | |
| IT1260656B (it) | Articolo assorbente comprendente un materiale per il controllo dell'odore e relativo impiego. | |
| HUT34348A (en) | New process for producing immunotoxin conjugates | |
| SE9504077D0 (sv) | Vätskeabsorberande artikel ansedd för engångsanvändning | |
| ZA848156B (en) | Compounds having antiinflammatory activity,obtained by complexation with beta-cyclodextrin,and pharmaceutical compositions containing them | |
| ATE190501T1 (de) | Bereitstellung einer für krebszellen cytotoxischen verbindung unter verwendung des weges von plasminogenaktivatormaterial | |
| ATE187491T1 (de) | Isolierung, selektion und vermehrung von tierischen transgen-stammzellen | |
| DE69414369D1 (de) | Aerosol-spender und verfahren zu seiner herstellung | |
| JPS5535019A (en) | Carbostyryl derivative | |
| ATE47711T1 (de) | Biologisch aktive verbindung mit anti-prolyl endopeptidasewirkung. | |
| ES449284A1 (es) | Perfeccionamientos introducidos en un tubo de envase. | |
| ATE160700T1 (de) | Konjugate von biotin und deferoxamine für radio- immuntherapie und -immunbilderzeugung | |
| DE3173520D1 (en) | Shampoo composition | |
| ES482808A1 (es) | Un procedimiento para el mezclado continuo y uniforme de cantidades relativamente pequenas de aditivo liquido o li- cuado con cantidades relativamente grandes de material gra- nulado solido | |
| DE69015182D1 (de) | Thrombus-gerichtete komplexe, die aus plasminogenaktivator und fibrinfragmenten zusammengesetzt sind. | |
| GB9315253D0 (en) | Chemical compounds | |
| AU5976494A (en) | Oxidising agents | |
| ES8401335A1 (es) | Procedimiento y dispositivo para encolar material particulado especialmente virutas lignocelulosicas. | |
| ES2109182A1 (es) | Formulacion liquida a base de cepas de los hongos filamentosos trichoderma harzianum y trichoderma viride. | |
| UA29392C2 (uk) | Пакувальний контейнер | |
| AU3332389A (en) | Monoclonal antibodies to tissue plasminogen activator (t-pa) which prolong its functional half-life | |
| FR2506831A1 (fr) | Procede de guidage d'une machine de forage en utilisant la radioactivite naturelle | |
| MX9307040A (es) | Material hidrodesintegrable y productos formados con el mismo. | |
| MX9602816A (es) | Un lapiz que tiene una ferula que sostiene una goma asegurada mediante soldeo ultrasonico, y una ferula adaptada para ese proposito. | |
| MX9303136A (es) | Metodo de entrega de un compuesto citotoxico a una celula cancerosa, que usa una trayectoria de material activo biologicamente. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |